Suzanne Louise Bruhn - Net Worth and Insider Trading

Suzanne Louise Bruhn Net Worth

The estimated net worth of Suzanne Louise Bruhn is at least $435,933 dollars as of 2024-05-05. Suzanne Louise Bruhn is the Director of Raptor Pharmaceutical Corp and owns about 48,437 shares of Raptor Pharmaceutical Corp (RPTP) stock worth over $435,933. Details can be seen in Suzanne Louise Bruhn's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Suzanne Louise Bruhn has not made any transactions after 2015-09-09 and currently still holds the listed stock(s).

Transaction Summary of Suzanne Louise Bruhn

To

Suzanne Louise Bruhn Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Suzanne Louise Bruhn owns 8 companies in total, including Avalo Therapeutics Inc (AVTX) , Spyre Therapeutics Inc (SYRE) , and Pliant Therapeutics Inc (PLRX) among others .

Click here to see the complete history of Suzanne Louise Bruhn’s form 4 insider trades.

Insider Ownership Summary of Suzanne Louise Bruhn

Ticker Comapny Transaction Date Type of Owner
AVTX Avalo Therapeutics Inc 2020-06-18 director
SYRE Spyre Therapeutics Inc 2017-02-15 director
PLRX Pliant Therapeutics Inc 2020-06-02 director
2020-04-08 director
2018-08-09 director
2016-10-24 director
2022-07-27 director
2022-08-11 director

Suzanne Louise Bruhn Latest Holdings Summary

Suzanne Louise Bruhn currently owns a total of 1 stock. Suzanne Louise Bruhn owns 48,437 shares of Raptor Pharmaceutical Corp (RPTP) as of September 9, 2015, with a value of $435,933.

Latest Holdings of Suzanne Louise Bruhn

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RPTP Raptor Pharmaceutical Corp 2015-09-09 48,437 9.00 435,933

Holding Weightings of Suzanne Louise Bruhn


Suzanne Louise Bruhn Form 4 Trading Tracker

According to the SEC Form 4 filings, Suzanne Louise Bruhn has made a total of 0 transactions in Raptor Pharmaceutical Corp (RPTP) over the past 5 years. The most-recent trade in Raptor Pharmaceutical Corp is the sale of 18,258 shares on September 9, 2015, which brought Suzanne Louise Bruhn around $227,677.

Insider Trading History of Suzanne Louise Bruhn

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Suzanne Louise Bruhn Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Suzanne Louise Bruhn Ownership Network

Ownership Network List of Suzanne Louise Bruhn

No Data

Ownership Network Relation of Suzanne Louise Bruhn


Suzanne Louise Bruhn Owned Company Details

What does Avalo Therapeutics Inc do?

Who are the key executives at Avalo Therapeutics Inc?

Suzanne Louise Bruhn is the director of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .

Avalo Therapeutics Inc (AVTX) Insider Trades Summary

Over the past 18 months, Suzanne Louise Bruhn made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 206,169 shares made by Caissa Capital Management Ltd. , a net sale of 3,233,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 6,083 shares made by Garry Arthur Neil .

In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 2,762 shares were bought by its insiders, resulting in a net sale of 12,587 shares.

Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Avalo Therapeutics Inc Insider Transactions

No Available Data

Suzanne Louise Bruhn Mailing Address

Above is the net worth, insider trading, and ownership report for Suzanne Louise Bruhn. You might contact Suzanne Louise Bruhn via mailing address: C/o Aeglea Biotherapeutics, Inc., 901 S. Mopac Expressway, Suite 250, Austin Tx 78746.

Discussions on Suzanne Louise Bruhn

No discussions yet.